Investigation Report on China Menotropins Market, 2010-2019
Description
According to the statistics, at present there are about 100 million women in the high-fertility period (aged 20-29) in China, over 12% of whom suffer from infertility. About 30% of female diagnosed with infertility suffer from ovulation inhibition. Herein it can be estimated that the number of potential patients suffering from ovulation inhibition is larger than 3.6 million. Popular clinic drugs utilized in the treatment of ovulation inhibition include clomifene citrate, and gonadotropin (mainly classified into follicle stimulating hormone, menotropins and chorionic gonadotrophin). Gonadotropin is usually utilized if clomifene citrate doesn’t work, and sometimes utilized together with clomifene citrate to promote ovulation. chorionic gonadotrophin in combination with follicle stimulating hormone or menotrophins are often applied in the clinic. That is to say,, follicle stimulating hormone or menotrophins is utilized first to foster the growth and maturation of follicle, and then chorionic gonadotrophin is utilized to stimulate ovulation and provide luteal support.
As one of the earliest ovulation stimulants utilized in the clinic, menotropins was utilized in the clinic as early as the 1960s. Extracted from urines of post-menopausal women, menotropins is mainly composed of 75IU ovulation stimulant and 75IU luteinizing hormone. It fosters the growth and maturation of ovulation and affiliates secretion of estrogen within the follicle. In China, there are plenty of manufacturers of menotropins. However, the quality of menotropins produced by these manufacturers is uneven. Menotropins produced by Livzon Pharmaceutical Group Inc, with high purity and outstanding quality, enjoys individual pricing of the development and reform committee, thus its bidding price is slightly higher than that of other manufacturers.
Menotropins has been growing at a rapid pace after entering the Chinese market, with its annual sales value rising from less than CNY 20 million in 2005 to CNY 79.1 million in 2014 and its CAGR from 2005 to 2014 reaching 22.8%. Chinese menotrohins market is mainly dominated by Livzon Pharmaceutical, Livzon Pharmaceutical Group, Inc, Ferring Pharmaceytical Co., Ltd (Germany), Ma’anshan Fengyuan Pharmaceutical Co., Ltd, Yantai North Pharmaceutical Co., Ltd and Shanghai Livzon Pharmaceutical Co., Ltd, among which Shanghai Livzon Pharmaceutical Co., Ltd owns the largest market share, market share for sales value exceeding 60% in 2004.
Readers can have access to the following information through this report:
According to the statistics, at present there are about 100 million women in the high-fertility period (aged 20-29) in China, over 12% of whom suffer from infertility. About 30% of female diagnosed with infertility suffer from ovulation inhibition. Herein it can be estimated that the number of potential patients suffering from ovulation inhibition is larger than 3.6 million. Popular clinic drugs utilized in the treatment of ovulation inhibition include clomifene citrate, and gonadotropin (mainly classified into follicle stimulating hormone, menotropins and chorionic gonadotrophin). Gonadotropin is usually utilized if clomifene citrate doesn’t work, and sometimes utilized together with clomifene citrate to promote ovulation. chorionic gonadotrophin in combination with follicle stimulating hormone or menotrophins are often applied in the clinic. That is to say,, follicle stimulating hormone or menotrophins is utilized first to foster the growth and maturation of follicle, and then chorionic gonadotrophin is utilized to stimulate ovulation and provide luteal support.
As one of the earliest ovulation stimulants utilized in the clinic, menotropins was utilized in the clinic as early as the 1960s. Extracted from urines of post-menopausal women, menotropins is mainly composed of 75IU ovulation stimulant and 75IU luteinizing hormone. It fosters the growth and maturation of ovulation and affiliates secretion of estrogen within the follicle. In China, there are plenty of manufacturers of menotropins. However, the quality of menotropins produced by these manufacturers is uneven. Menotropins produced by Livzon Pharmaceutical Group Inc, with high purity and outstanding quality, enjoys individual pricing of the development and reform committee, thus its bidding price is slightly higher than that of other manufacturers.
Menotropins has been growing at a rapid pace after entering the Chinese market, with its annual sales value rising from less than CNY 20 million in 2005 to CNY 79.1 million in 2014 and its CAGR from 2005 to 2014 reaching 22.8%. Chinese menotrohins market is mainly dominated by Livzon Pharmaceutical, Livzon Pharmaceutical Group, Inc, Ferring Pharmaceytical Co., Ltd (Germany), Ma’anshan Fengyuan Pharmaceutical Co., Ltd, Yantai North Pharmaceutical Co., Ltd and Shanghai Livzon Pharmaceutical Co., Ltd, among which Shanghai Livzon Pharmaceutical Co., Ltd owns the largest market share, market share for sales value exceeding 60% in 2004.
Readers can have access to the following information through this report:
- market size of menotropins in China
- competitive landscape of menotropins in the Chinese market
- prices of menotropins produced by different enterprises in China
- market outlook of menotropins in China
- manufacturers of endocrine and metabolic regulation drugs
- investors/ research institutions interested in Chinese medicine market
- any interest in the Chinese medicine market, please contact CRI for customized survey service
1 RELATED CONCEPTS OF MENOTROPINS
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF MENOTROPINS IN CHINA
2.1 Patent and Approval Status of Menotropins in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES STATUS OF MENOTROPINS IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF MENOTROPINS IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF MENOTROPINS IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF MENOTROPINS IN CHINESE HOSPITALS IN 2014
6.1 Shanghai Livzon Pharmaceutical Co., Ltd
6.2 Livzon Pharmaceutical, Livzon Pharmaceutical Group, Inc
6.3 Yantai North Pharmaceutical Co., Ltd
6.4 Ferring Pharmaceytical Co., Ltd (Germany)
6.5 Ma’anshan Fengyuan Pharmaceutical Co., Ltd
6.6 Ningbo Renjian Pharmaceutical Co., Ltd
7 MAJOR MANUFACTURERS OF MENOTROPINS IN CHINESE MARKET, 2010-2014
7.1 Livzon Pharmaceutical, Livzon Pharmaceutical Group, Inc
7.2 Yantai North Pharmaceutical Co., Ltd
7.3 Ma’anshan Fengyuan Pharmaceutical Co., Ltd
7.4 Ferring Pharmaceytical Co., Ltd (Germany)
7.5 Shanghai Livzon Pharmaceutical Co., Ltd
8 MARKET OUTLOOK OF MENOTROPINS IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF MENOTROPINS IN CHINA
2.1 Patent and Approval Status of Menotropins in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES STATUS OF MENOTROPINS IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF MENOTROPINS IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF MENOTROPINS IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF MENOTROPINS IN CHINESE HOSPITALS IN 2014
6.1 Shanghai Livzon Pharmaceutical Co., Ltd
6.2 Livzon Pharmaceutical, Livzon Pharmaceutical Group, Inc
6.3 Yantai North Pharmaceutical Co., Ltd
6.4 Ferring Pharmaceytical Co., Ltd (Germany)
6.5 Ma’anshan Fengyuan Pharmaceutical Co., Ltd
6.6 Ningbo Renjian Pharmaceutical Co., Ltd
7 MAJOR MANUFACTURERS OF MENOTROPINS IN CHINESE MARKET, 2010-2014
7.1 Livzon Pharmaceutical, Livzon Pharmaceutical Group, Inc
7.2 Yantai North Pharmaceutical Co., Ltd
7.3 Ma’anshan Fengyuan Pharmaceutical Co., Ltd
7.4 Ferring Pharmaceytical Co., Ltd (Germany)
7.5 Shanghai Livzon Pharmaceutical Co., Ltd
8 MARKET OUTLOOK OF MENOTROPINS IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
SELECTED CHARTS
Chart Approval Information of Menotropins in China
Chart Sales Status of Menotropins in Chinese Market, 2010-2014
Chart Sales Value of Menotropins in China, 2010-2014
Chart Sales Value of Menotropins in Some Regions of China, 2010-2014
Chart Sales Volume of Menotropins in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Menotropins for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Menotropins Produced by Livzon Pharmaceutical Co., Ltd in China, 2010-2014
Chart Sales Value and Market Share of Menotropins Produced by Ferring Pharmaceutical Co., Ltd (Germany) in China, 2010-2014
Chart Sales Value and Market Share of Menotropins Produced by Shanghai Livzon Pharmaceutical Co., Ltd in China, 2010-2014
Chart Sales Value and Market Share of Menotropins Produced by Yantai North Pharmaceutical Co., Ltd in China, 2010-2014
Chart Sales Value and Market Share of Menotropins Produced by Ma’anshan Fengyuan Pharmaceutical Co., Ltd in China, 2010-2014
Chart Price of Menotropins Produced by Shanghai Livzon Pharmaceutical Co., Ltd in Some Cities of China in 2014
Chart Price of Menotropins Produced by Livzon Pharmaceutical, Livzon Pharmaceutical Group Inc in Some Cities of China in 2014
Chart Price of Menotropins Produced by Yantai North Pharmaceutical Co., Ltd in Some Cities of China in 2014
Chart Price of Menotropins Produced by Ferring Pharmaceutical Co., Ltd in Some Cities of China in 2014
Chart Price of Menotropins Produced by Ma’anshan Fengyuan Pharmaceutical Co., Ltd in Some Cities of China in 2014
Chart Price of Menotropins Produced by Ningbo Renjian Pharmaceutical Co., Ltd in Some Cities of China in 2014
Chart Approval Information of Menotropins in China
Chart Sales Status of Menotropins in Chinese Market, 2010-2014
Chart Sales Value of Menotropins in China, 2010-2014
Chart Sales Value of Menotropins in Some Regions of China, 2010-2014
Chart Sales Volume of Menotropins in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Menotropins for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Menotropins Produced by Livzon Pharmaceutical Co., Ltd in China, 2010-2014
Chart Sales Value and Market Share of Menotropins Produced by Ferring Pharmaceutical Co., Ltd (Germany) in China, 2010-2014
Chart Sales Value and Market Share of Menotropins Produced by Shanghai Livzon Pharmaceutical Co., Ltd in China, 2010-2014
Chart Sales Value and Market Share of Menotropins Produced by Yantai North Pharmaceutical Co., Ltd in China, 2010-2014
Chart Sales Value and Market Share of Menotropins Produced by Ma’anshan Fengyuan Pharmaceutical Co., Ltd in China, 2010-2014
Chart Price of Menotropins Produced by Shanghai Livzon Pharmaceutical Co., Ltd in Some Cities of China in 2014
Chart Price of Menotropins Produced by Livzon Pharmaceutical, Livzon Pharmaceutical Group Inc in Some Cities of China in 2014
Chart Price of Menotropins Produced by Yantai North Pharmaceutical Co., Ltd in Some Cities of China in 2014
Chart Price of Menotropins Produced by Ferring Pharmaceutical Co., Ltd in Some Cities of China in 2014
Chart Price of Menotropins Produced by Ma’anshan Fengyuan Pharmaceutical Co., Ltd in Some Cities of China in 2014
Chart Price of Menotropins Produced by Ningbo Renjian Pharmaceutical Co., Ltd in Some Cities of China in 2014
